OCEAN BIOMEDICAL INC (OCEA) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:OCEA • US67644C1045

0.0205 USD
-0.02 (-46.75%)
At close: Apr 23, 2025
0.02 USD
0 (-2.44%)
After Hours: 4/23/2025, 8:26:33 PM
Fundamental Rating

0

OCEA gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. Both the profitability and financial health of OCEA have multiple concerns. OCEA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year OCEA has reported negative net income.
  • OCEA had a negative operating cash flow in the past year.
OCEA Yearly Net Income VS EBIT VS OCF VS FCFOCEA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

  • OCEA's Return On Assets of -1051.00% is on the low side compared to the rest of the industry. OCEA is outperformed by 98.41% of its industry peers.
Industry RankSector Rank
ROA -1051%
ROE N/A
ROIC N/A
ROA(3y)-1044.23%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OCEA Yearly ROA, ROE, ROICOCEA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for OCEA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OCEA Yearly Profit, Operating, Gross MarginsOCEA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

0

2. Health

2.1 Basic Checks

  • OCEA has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for OCEA is higher compared to a year ago.
OCEA Yearly Shares OutstandingOCEA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
OCEA Yearly Total Debt VS Total AssetsOCEA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • OCEA has an Altman-Z score of -376.89. This is a bad value and indicates that OCEA is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -376.89, OCEA is not doing good in the industry: 98.41% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -376.89
ROIC/WACCN/A
WACCN/A
OCEA Yearly LT Debt VS Equity VS FCFOCEA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

  • OCEA has a Current Ratio of 0.02. This is a bad value and indicates that OCEA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.02, OCEA is not doing good in the industry: 98.59% of the companies in the same industry are doing better.
  • OCEA has a Quick Ratio of 0.02. This is a bad value and indicates that OCEA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.02, OCEA is doing worse than 98.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
OCEA Yearly Current Assets VS Current LiabilitesOCEA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M

0

3. Growth

3.1 Past

  • OCEA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 90.24%, which is quite impressive.
EPS 1Y (TTM)90.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.65%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OCEA Yearly EPS VS EstimatesOCEA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 -1 -2 -3

0

4. Valuation

4.1 Price/Earnings Ratio

  • OCEA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OCEA Price Earnings VS Forward Price EarningsOCEA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OCEA Per share dataOCEA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.1 -0.2 -0.3 -0.4 -0.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for OCEA!.
Industry RankSector Rank
Dividend Yield N/A

OCEAN BIOMEDICAL INC / OCEA FAQ

What is the ChartMill fundamental rating of OCEAN BIOMEDICAL INC (OCEA) stock?

ChartMill assigns a fundamental rating of 0 / 10 to OCEA.


What is the valuation status of OCEAN BIOMEDICAL INC (OCEA) stock?

ChartMill assigns a valuation rating of 0 / 10 to OCEAN BIOMEDICAL INC (OCEA). This can be considered as Overvalued.


How profitable is OCEAN BIOMEDICAL INC (OCEA) stock?

OCEAN BIOMEDICAL INC (OCEA) has a profitability rating of 0 / 10.


What is the financial health of OCEAN BIOMEDICAL INC (OCEA) stock?

The financial health rating of OCEAN BIOMEDICAL INC (OCEA) is 0 / 10.